Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,477 total articles
McCormick (MKC) offers a compelling risk-reward: an immediate yield around 4%, solid free cash flow of about $1.02B, and a valuation that looks compressed at roughly 8.5x earnings. Combine that with an active M&A backdrop and the pending Unilever foods deal and you have a tactical long with defined risk to capture roughly 35% upside to $69 over a 1…
Lenovo's PC business still gets headlines, but the company is executing an AI infrastructure pivot: AI revenue grew 84% and now accounts for 38% of the quarter, supported by a $15.5B AI server pipeline and partnerships with NVIDIA. With a market cap of roughly $37.5B and a P/E of ~19.6, the stock looks tradeable to the long side as the market re-ra…
Enterprise Products Partners (EPD) offers a durable 5.9% yield, $2.2B in free cash flow and a conservative valuation (P/E ~13.4, EV/EBITDA 11.6). Against MPLX, EPD's sheer scale, diversified fee-based cash flows and stronger free cash generation make it my preferred long trade for a 180-trading-day horizon. Trade plan: long EPD at $36.58, stop $33.…
Alphabet's shares have retraced into the mid-$300s after a strong run into May. Fundamentals - $64.4B free cash flow, a $4.07T market cap, 33% return on equity - and ongoing hyperscaler AI capex argue this dip is a buying opportunity. This trade lays out precise entry, stop and target with horizon and risk framing.
Pilbara Minerals (PILBF) is trading below its short- and medium-term moving averages and shows oversold momentum, while short interest remains extremely elevated. If the lithium cycle stabilizes and flows rotate back to survivors with scale, a conviction long with tight risk management offers asymmetric upside over the next 45 trading days.
Adobe (ADBE) has been punished by fears that generative AI will commoditize creative workflows and that a shift to freemium will shrink licenses. The fundamentals tell a different story: strong free cash flow, a low-teens P/E, and new AI product integrations that can expand monetization. This trade idea proposes a defined long with entry at $203.00…
Salesforce shares have been punished hard in the last year, but recent fundamental traction, strong free cash flow and a shallow valuation argue for a tactical long. This trade plan sets an entry at $158.30, a protective stop at $146.32 and a primary target of $210 over a 180-trading-day horizon, while acknowledging catalysts and key risks that cou…
SELLAS Life Sciences (SLS) has ripped to a 52-week high today, but technical and position data suggest an overbought setup and elevated squeeze risk. This idea recommends a tactical short into strength with a mid-term horizon while acknowledging the company’s CDK9 AML program is the longer-term asset investors should be following.
PagSeguro (PAGS) is trading at a single-digit P/E, sub-1x book value and yields a tangible quarterly payout. With a $2.51 billion market cap, consistent payment volumes and recent earnings beats, the risk/reward favors a long position. This trade lays out entry, stop and target levels for a 180-trading-day objective while highlighting catalysts and…
Aramark reported a modest Q1 beat and reiterated full-year guidance while showing strong new-business momentum and record client retention. Valuation is reasonable on an EV/sales basis but P/E is elevated; balance sheet leverage is meaningful. We initiate a tactical long trade that targets a re-rating as Nexus and digital services lift organic grow…
Pony AI trades like a beaten-down leader in China’s robotaxi race. With a $3.04B market cap, an oversold technical setup (RSI ~30), and visible commercial traction (Zagreb launch, Q4 revenue $29.1M), the risk-reward favors a tactical long. This trade targets $10.50 over ~45 trading days, with a hard stop at $6.10.
Bumble's AI push and improved EBITDA picture have turned a deteriorating user story into a conditional recovery. The shares trade near multi-year lows and carry a compelling valuation if the AI-driven product improvements scale; however, elevated leverage, choppy user trends and ongoing legal/noise risks make this a speculative hold rather than a b…
Tractor Supply (TSCO) screens inexpensive relative to recent history: market cap ~$16.4B, P/E ~15, and a 3% yield. Q1 weakness concentrated in pet food and traffic pressured shares, but management reiterated guidance and the business still generates solid cash flow. For patient investors, a long entry at $31.50 with a $45 target and $27.50 stop bal…
Uber just had a meaningful pullback to the mid-$60s earlier this month, but core business momentum - 25% gross bookings growth and $13.2B in revenue last quarter - plus a healthy free cash flow profile make this a compelling buy-the-dip swing trade. Use disciplined sizing and a tight stop below the $67 low to limit downside while targeting a move b…
British American Tobacco (BTI) trades at a modest multiple, yields ~4.9%, and is positioned to benefit from rapid growth in nicotine pouches (Velo). We lay out an actionable long trade with entry, stop, and target, plus catalysts and downside scenarios.
Micron sits at the center of an AI-driven memory supercycle. With HBM scarcity, fiscal Q3 revenue of $41.46B (345% YoY), a $30B cash war chest and guidance pointing to $50B next quarter, Micron can sustain a multi-quarter re-rating. This trade targets $1,800 with a $900 stop, sized for traders who can withstand elevated cyclicality and headline ris…
AppLovin's AI-driven ad stack and recent beat-and-raise momentum set up a high-reward trade. We lay out an entry at current levels, a $710 upside target tied to multiple expansion and execution, and a disciplined stop at $425 to control downside.
Titan Mining presents a compact risk-reward: a low-market-cap zinc play that could benefit from higher zinc prices and U.S. critical-minerals policy support. This is a structured long with a clear entry, stop and target for a 180-trading-day horizon, balanced against permitting and financing risks.
Graham Holdings (GHC) is a diversified holding company trading around $1,160 with a market cap near $5.0B, P/B ~1.04 and P/E ~16.8. Strong free cash flow, low leverage, and a mix of education, healthcare and broadcasting assets make the business defensible. We present a tactical long with an entry at $1,150, stop at $1,040 and target at $1,250 over…
United Parks & Resorts (PRKS) has been punished for attendance hiccups and earnings misses, but the underlying cash generation and valuation multiples argue for a long trade. I outline an actionable plan with entry, stop and target, explain the fundamental backdrop, list catalysts, and lay out the risks that could derail the thesis.
Precision Drilling trades at a sub-1 PB, sits near oversold technicals (RSI ~31.6) and has a compact market cap of roughly $1.0B. I plan a long trade at the current price with a $97 target over 180 trading days and a $72 stop — a trade that balances upside from a potential re-rating and operational improvement against clear cyclical and execution r…
Precigen is showing the first signs of commercial scale after FDA approval of PAPZIMEOS: $21.6M in net product revenue in the first full quarter, permanent J-code reimbursement, broad payer coverage and a path to cash-flow break-even by year-end. The stock carries lofty valuation multiples, heavy short interest and an overbought technical reading, …
KULR Technology Group ($KULR) remains a compelling takeover candidate based on proprietary carbon-fiber thermal products, recent strategic collaborations, constrained market value (EV ~$170M), and a sizeable short interest that can amplify moves. This trade idea lays out an actionable long with entry, stop, and target, plus catalysts and risks to w…
MoonLake Immunotherapeutics is a clinical-stage biotech with a single major value driver: sonelokimab. With Phase 3 Week-40 results showing durable responses and management targeting a BLA submission in H2 2026, MLTX offers an asymmetric risk/reward for a disciplined long trade. The company has meaningful cash per share and an upcoming regulatory c…
Spyre Therapeutics has pivoted from single-agent binary risk toward a deliberately engineered combination strategy. Positive Phase 2 SKYLINE Part A results for SPY001, an upsized $403M financing, and a deepening commercial bench justify a mid-term long trade that targets upside toward the 52-week range while respecting biotech volatility with a tig…
